Sujjitjoon J, Ng WL, Kongkla K, Jarutatsanangkoon K, Chongsutakawewong K, Subhadhirasakul S, Uiprasertkul M, Udompunturak S, Junking M, Yenchitsomanus PT, Atchaneeyasakul LO.
B7-H3 and GD2 overexpression as immunotherapeutic targets in retinoblastoma
Sci Rep.
2026.
16
(1):
2.
Kuljarusnont S, Karnchanabanyong W, Ruengkhachorn I, Ularnwong M, Ittiamornlert P, Hanamornroongruang S.
Comparative Performance of Visual Inspection with Acetic Acid and Colposcopy for Detection of Cervical Precancer in Women with High-Risk Human Papillomavirus Infection: A Cross-Sectional Study
Cancer Control.
2026.
33
Self-differentiated Dendritic Cells Presenting NY-ESO-1 Prime Cytotoxic T Cells for the Treatment of Multiple Myeloma
Anticancer Research.
2026.
46
(1):
249-262.
5.
Songprakhon P, Luangwattananun P, Choomee K, Sawasdee N, Somboonpatarakun C, Chieochansin T, Sukpanichnant S, Junking M, Okada S, Yenchitsomanus PT.
CD138-targeted bispecific protein engager-armed T cells exhibit potent and selective cytotoxicity against multiple myeloma cells
Int Immunopharmacol.
2026.
174